Atlas Trials

Real World Data Study Assessing The Persistency Of Xalacom And The Other Fixed Dose Combination Products, Duotrav And Ganfort, In The United Kingdom

Clinical trial NCT01206361 · COMPLETED

Trial details

NCT number
NCT01206361
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Status
COMPLETED
Study type
OBSERVATIONAL
GlaucomaOcular Hypertension
Start date
2010-02-01
Primary completion
2010-08-01
Enrollment
2015

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.